Positron emission tomography and perfusion weighted imaging in the detection of brain tumors recurrence: A meta-analysis

TS Daqqaq, AS Alhasan - Neurosciences Journal, 2022 - nsj.org.sa
Objectives: To assess and compare the diagnostic accuracy, sensitivity and specificity of
perfusion-weighted imaging (PWI) and positron emission tomography (PET) in …

[PDF][PDF] Head-To-Head Comparison of PET and Perfusion Weighted MRI Techniques to Distinguish Treatment Related Abnormalities from Tumor Progression in Glioma …

D Henssen, L Leijten, FJA Meijer, A van der Kolk… - 2023 - pure.eur.nl
The post-treatment imaging surveillance of gliomas is challenged by distinguishing tumor
progression (TP) from treatment-related abnormalities (TRA). Sophisticated imaging …

[HTML][HTML] Head-to-head comparison of PET and perfusion weighted MRI techniques to distinguish treatment related abnormalities from tumor progression in glioma

D Henssen, L Leijten, FJA Meijer, A van der Kolk… - Cancers, 2023 - mdpi.com
Simple Summary This meta-analysis provides a first head-to-head comparison of PET and
perfusion weighted magnetic resonance imaging (PWI) in the surveillance of post-treatment …

[HTML][HTML] Neuro-Oncology and Positron Emission Tomography:“Just Can't Get Enough”

B Muoio, V Espeli, G Treglia - Cancers, 2023 - mdpi.com
Imaging has a pivotal role in neuro-oncology for the management of primary and secondary
brain tumors. To this regard, positron emission tomography (PET) is increasingly used to …

[PDF][PDF] Value of magnetic resonance spectroscopy and perfusion-weighted imaging in distinguishing glioma recurrence from PTRE: a meta-analysis

Y Shan, X Chen, Y Lin, Y Wang, S Zhong, Y Gong - Int J Clin Exp Med, 2016 - e-century.us
Background and purpose: Nowadays, radiation therapy has become a gold standard
treatment for gliomas, especially for high grade gliomas. Unfortunately, posttreatment …

Detection of glioma recurrence by 11C-methionine positron emission tomography and dynamic susceptibility contrast-enhanced magnetic resonance imaging: a meta …

SM Deng, B Zhang, YW Wu, W Zhang… - Nuclear Medicine …, 2013 - journals.lww.com
Purpose This study aimed to compare the diagnostic value of 11 C-methionine (11 C-MET)
PET and dynamic susceptibility contrast-enhanced (DSCE) MRI in detecting glioma …

Diagnostic value of PET with different radiotracers and MRI for recurrent glioma: a Bayesian network meta-analysis

T Xiaoxue, W Yinzhong, Q Meng, X Lu, J Lei - BMJ open, 2023 - bmjopen.bmj.com
Objective The purpose of this study was to evaluate the diagnostic accuracy of 6 different
imaging modalities for differentiating glioma recurrence from postradiotherapy changes by …

OS4. 3 Diagnostic performance of static 18F-fluoroethyl-L-tyrosine positron emission tomography parameters to differentiate recurrent brain tumours from non …

B Muoio, G Treglia, M Reinert, A Richetti, L Giovanella… - 2016 - academic.oup.com
Purpose: Response assessment in brain tumors is currently done with the 2D Response
Assessment in Neuro-Oncology (RANO) criteria. However, bevacizumab-treated patients …

[HTML][HTML] Diagnostic accuracy of PET for differentiating true glioma progression from post treatment-related changes: a systematic review and meta-analysis

M Cui, RI Zorrilla-Veloz, J Hu, B Guan, X Ma - Frontiers in Neurology, 2021 - frontiersin.org
Purpose: To evaluate the diagnostic accuracy of PET with different radiotracers and
parameters in differentiating between true glioma progression (TPR) and post treatment …

Umbrella review and network meta-analysis of diagnostic imaging test accuracy studies in Differentiating between brain tumor progression versus pseudoprogression …

R Dagher, M Gad, P da Silva de Santana… - Journal of neuro …, 2024 - Springer
Purpose In this study we gathered and analyzed the available evidence regarding 17
different imaging modalities and performed network meta-analysis to find the most effective …